Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Fulvestrant [fulvestrant]
topical
57
- Terms
-
Faslodex
-
7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol
Faslodex
ICI 182,780
ICI 182780
ICI-182780
ZM 182780
ZM-182780
Persistent link
https://www.medvik.cz/link/D000077267
Definition
An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer.
- DUI
- D000077267 MeSH Browser
- CUI
- M0397101
- History note
- 2019 (1991)
- Public note
- 2019; FULVESTRANT was indexed under ESTRADIOL/analogs & derivatives 1991-2019
Allowable subheadings
- AD
- administration & dosage 17
- AE
- adverse effects 7
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics 2
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 7
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 18
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D04.210
Fused-Ring Compounds
D04.210.500.365.415.248.830
2-Methoxyestradiol
D06.472.334.851.437.500.750
2-Methoxyestradiol